Valuation GC Genome Corporation

Stocks

End-of-day quote Korea S.E. 2026-09-23			5-day change	1st Jan Change
8,180.00 ^KRW	+12.21%		+21.55%	+19.94%

12-09	GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy	CI
25-06-12	GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2025	2026	2027
Market Cap ¹	161,298	193,463	-
Change	-	19.94%	-
Enterprise Value (EV) ¹	161.3	134.1	124.7
Change	-	-16.88%	-7.01%
P/E	36.9x	-	-
PBR	-	-	-
PEG	-0x	-	-
Capitalization / Revenue	-	4.96x	3.96x
EV / Revenue	-	3.44x	2.55x
EV / EBITDA	-	-	-
EV / EBIT	-	33.5x	17.8x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ³	-	-	-
Rate of return	-	-	-
EPS ³	185	-	-
Distribution rate	-	-	-
Net sales ¹	-	39	48.8
EBITDA	-	-	-
EBIT ¹	-	4	7
Net income	4.044	-	-
Net Debt ¹	-	-59.4	-68.8
Reference price ³	6,820.00	8,180.00	8,180.00
Nbr of stocks (in thousands)	23,651	23,651	-
Announcement Date	3/16/26	-	-

¹KRW in Million²KRW in Billions³KRW

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GC GENOME CORPORATION	-	3.44x	-	-	142M
NATERA, INC.	-286.88x	18.99x	-341.11x	-.--%	56.33B
LABCORP HOLDINGS INC.	21.82x	2.02x	11.43x	0.96%	24.65B
SONIC HEALTHCARE LIMITED	15.5x	1.24x	7.02x	5.65%	6.62B
RADNET, INC.	1045.86x	-	-	-	5.76B
DR. LAL PATHLABS LIMITED	52x	9.6x	33.03x	0.96%	3.36B
GENEDX HOLDINGS CORP.	-25.39x	-	-	-	2.54B
NEOGENOMICS, INC.	-61.97x	-	-	-.--%	2.36B
FLEURY S.A.	15.91x	1.66x	6.48x	4.87%	2.32B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	32.85x	1.73x	12.93x	1.37%	1.98B
Average	89.97x	5.52x	-45.04x	1.97%	10.61B
Weighted average by Cap.	-89.01x	12.24x	-196.69x	0.8%